{
  "drug_name": "Warfarin_reversal",
  "url": "https://wikem.org/wiki/Warfarin_reversal",
  "scraped_at": "2026-01-10T08:05:19.357557",
  "sections": {
    "Background": {
      "text": "For supratheraputic INR on warfarin\nIntracranial hemorrhage is significantly increased with an INR > 4.0\n[1]",
      "subsections": {
        "Target_INR": {
          "text": "Vascular thrombosis (DVT, PE): 2.0-3.0\nMost mechanical heart valves: 3.0-4.5\nBileaflet mechanical aortic heart valves: 2.5-3.5",
          "tables": []
        },
        "Risk_Factors_for_INR_>_6.0": {
          "text": "",
          "tables": [
            [
              {
                "Risk Factor": "Malignancy",
                "Odds Ratio": "16.4"
              },
              {
                "Risk Factor": "Tylenol Intake > 9100 mg/week",
                "Odds Ratio": "10"
              },
              {
                "Risk Factor": "New Medication",
                "Odds Ratio": "8.5"
              },
              {
                "Risk Factor": "Increased Warfarin Intake",
                "Odds Ratio": "8.1"
              },
              {
                "Risk Factor": "Tylenol Intake 4550 mg - 9099 mg/week",
                "Odds Ratio": "6.9"
              },
              {
                "Risk Factor": "Decrease Vitamin K intake",
                "Odds Ratio": "3.6"
              },
              {
                "Risk Factor": "Acute Diarrheal Illness",
                "Odds Ratio": "3.5"
              }
            ]
          ]
        }
      },
      "tables": [],
      "links": []
    },
    "Target_INR": {
      "text": "Vascular thrombosis (DVT, PE): 2.0-3.0\nMost mechanical heart valves: 3.0-4.5\nBileaflet mechanical aortic heart valves: 2.5-3.5",
      "subsections": {
        "Risk_Factors_for_INR_>_6.0": {
          "text": "",
          "tables": [
            [
              {
                "Risk Factor": "Malignancy",
                "Odds Ratio": "16.4"
              },
              {
                "Risk Factor": "Tylenol Intake > 9100 mg/week",
                "Odds Ratio": "10"
              },
              {
                "Risk Factor": "New Medication",
                "Odds Ratio": "8.5"
              },
              {
                "Risk Factor": "Increased Warfarin Intake",
                "Odds Ratio": "8.1"
              },
              {
                "Risk Factor": "Tylenol Intake 4550 mg - 9099 mg/week",
                "Odds Ratio": "6.9"
              },
              {
                "Risk Factor": "Decrease Vitamin K intake",
                "Odds Ratio": "3.6"
              },
              {
                "Risk Factor": "Acute Diarrheal Illness",
                "Odds Ratio": "3.5"
              }
            ]
          ]
        }
      },
      "tables": [],
      "links": []
    },
    "Risk_Factors_for_INR_>_6.0": {
      "text": "",
      "subsections": {},
      "tables": [
        [
          {
            "Risk Factor": "Malignancy",
            "Odds Ratio": "16.4"
          },
          {
            "Risk Factor": "Tylenol Intake > 9100 mg/week",
            "Odds Ratio": "10"
          },
          {
            "Risk Factor": "New Medication",
            "Odds Ratio": "8.5"
          },
          {
            "Risk Factor": "Increased Warfarin Intake",
            "Odds Ratio": "8.1"
          },
          {
            "Risk Factor": "Tylenol Intake 4550 mg - 9099 mg/week",
            "Odds Ratio": "6.9"
          },
          {
            "Risk Factor": "Decrease Vitamin K intake",
            "Odds Ratio": "3.6"
          },
          {
            "Risk Factor": "Acute Diarrheal Illness",
            "Odds Ratio": "3.5"
          }
        ]
      ],
      "links": []
    },
    "Treatment_based_on_INR": {
      "text": "",
      "subsections": {
        "INR_4.5-10_No_Bleeding": {
          "text": "Hold Warfarin\nResume Warfarin at lower dose once INR therapeutic\nNot recommended to give Vitamin K",
          "tables": []
        },
        "INR_>10_No_Bleeding": {
          "text": "Hold Warfarin\nVitamin K\n2.5mg oral",
          "tables": []
        },
        "Major_Bleeding": {
          "text": "Stop warfarin\nGive\nVitamin K\n5-10mg IV INR will decrease over 24-48 hours (small risk of\nanaphylaxis\nwith IV\nVitamin K\n)\nGive 4 Factor\nprothrombin complex concentrate\n(PCC)\nIf no PCC, then give 15 ml/kg\nfresh frozen plasma\n(no benefit to combining\nPCC\nand\nFFP\n)\nConsult cardiology in conjunction with hematology if patient has prosthetic valve",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Vitamin K",
          "url": "https://wikem.org/wiki/Vitamin_K"
        },
        {
          "text": "Vitamin K",
          "url": "https://wikem.org/wiki/Vitamin_K"
        },
        {
          "text": "anaphylaxis",
          "url": "https://wikem.org/wiki/Anaphylaxis"
        },
        {
          "text": "Vitamin K",
          "url": "https://wikem.org/wiki/Vitamin_K"
        },
        {
          "text": "prothrombin complex concentrate",
          "url": "https://wikem.org/wiki/Prothrombin_complex_concentrate"
        },
        {
          "text": "fresh frozen plasma",
          "url": "https://wikem.org/wiki/Fresh_frozen_plasma"
        },
        {
          "text": "PCC",
          "url": "https://wikem.org/wiki/PCC"
        },
        {
          "text": "FFP",
          "url": "https://wikem.org/wiki/FFP"
        }
      ]
    },
    "INR_4.5-10_No_Bleeding": {
      "text": "Hold Warfarin\nResume Warfarin at lower dose once INR therapeutic\nNot recommended to give Vitamin K",
      "subsections": {
        "INR_>10_No_Bleeding": {
          "text": "Hold Warfarin\nVitamin K\n2.5mg oral",
          "tables": []
        },
        "Major_Bleeding": {
          "text": "Stop warfarin\nGive\nVitamin K\n5-10mg IV INR will decrease over 24-48 hours (small risk of\nanaphylaxis\nwith IV\nVitamin K\n)\nGive 4 Factor\nprothrombin complex concentrate\n(PCC)\nIf no PCC, then give 15 ml/kg\nfresh frozen plasma\n(no benefit to combining\nPCC\nand\nFFP\n)\nConsult cardiology in conjunction with hematology if patient has prosthetic valve",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Vitamin K",
          "url": "https://wikem.org/wiki/Vitamin_K"
        },
        {
          "text": "Vitamin K",
          "url": "https://wikem.org/wiki/Vitamin_K"
        },
        {
          "text": "anaphylaxis",
          "url": "https://wikem.org/wiki/Anaphylaxis"
        },
        {
          "text": "Vitamin K",
          "url": "https://wikem.org/wiki/Vitamin_K"
        },
        {
          "text": "prothrombin complex concentrate",
          "url": "https://wikem.org/wiki/Prothrombin_complex_concentrate"
        },
        {
          "text": "fresh frozen plasma",
          "url": "https://wikem.org/wiki/Fresh_frozen_plasma"
        },
        {
          "text": "PCC",
          "url": "https://wikem.org/wiki/PCC"
        },
        {
          "text": "FFP",
          "url": "https://wikem.org/wiki/FFP"
        }
      ]
    },
    "INR_>10_No_Bleeding": {
      "text": "Hold Warfarin\nVitamin K\n2.5mg oral",
      "subsections": {
        "Major_Bleeding": {
          "text": "Stop warfarin\nGive\nVitamin K\n5-10mg IV INR will decrease over 24-48 hours (small risk of\nanaphylaxis\nwith IV\nVitamin K\n)\nGive 4 Factor\nprothrombin complex concentrate\n(PCC)\nIf no PCC, then give 15 ml/kg\nfresh frozen plasma\n(no benefit to combining\nPCC\nand\nFFP\n)\nConsult cardiology in conjunction with hematology if patient has prosthetic valve",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Vitamin K",
          "url": "https://wikem.org/wiki/Vitamin_K"
        },
        {
          "text": "Vitamin K",
          "url": "https://wikem.org/wiki/Vitamin_K"
        },
        {
          "text": "anaphylaxis",
          "url": "https://wikem.org/wiki/Anaphylaxis"
        },
        {
          "text": "Vitamin K",
          "url": "https://wikem.org/wiki/Vitamin_K"
        },
        {
          "text": "prothrombin complex concentrate",
          "url": "https://wikem.org/wiki/Prothrombin_complex_concentrate"
        },
        {
          "text": "fresh frozen plasma",
          "url": "https://wikem.org/wiki/Fresh_frozen_plasma"
        },
        {
          "text": "PCC",
          "url": "https://wikem.org/wiki/PCC"
        },
        {
          "text": "FFP",
          "url": "https://wikem.org/wiki/FFP"
        }
      ]
    },
    "Major_Bleeding": {
      "text": "Stop warfarin\nGive\nVitamin K\n5-10mg IV INR will decrease over 24-48 hours (small risk of\nanaphylaxis\nwith IV\nVitamin K\n)\nGive 4 Factor\nprothrombin complex concentrate\n(PCC)\nIf no PCC, then give 15 ml/kg\nfresh frozen plasma\n(no benefit to combining\nPCC\nand\nFFP\n)\nConsult cardiology in conjunction with hematology if patient has prosthetic valve",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Vitamin K",
          "url": "https://wikem.org/wiki/Vitamin_K"
        },
        {
          "text": "anaphylaxis",
          "url": "https://wikem.org/wiki/Anaphylaxis"
        },
        {
          "text": "Vitamin K",
          "url": "https://wikem.org/wiki/Vitamin_K"
        },
        {
          "text": "prothrombin complex concentrate",
          "url": "https://wikem.org/wiki/Prothrombin_complex_concentrate"
        },
        {
          "text": "fresh frozen plasma",
          "url": "https://wikem.org/wiki/Fresh_frozen_plasma"
        },
        {
          "text": "PCC",
          "url": "https://wikem.org/wiki/PCC"
        },
        {
          "text": "FFP",
          "url": "https://wikem.org/wiki/FFP"
        }
      ]
    },
    "See_Also": {
      "text": "Coagulopathy (Main)\nWarfarin (Coumadin)\nAnticoagulant reversal for life-threatening bleeds",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Coagulopathy (Main)",
          "url": "https://wikem.org/wiki/Coagulopathy_(Main)"
        },
        {
          "text": "Warfarin (Coumadin)",
          "url": "https://wikem.org/wiki/Warfarin_(Coumadin)"
        },
        {
          "text": "Anticoagulant reversal for life-threatening bleeds",
          "url": "https://wikem.org/wiki/Anticoagulant_reversal_for_life-threatening_bleeds"
        }
      ]
    },
    "Video": {
      "text": "{{#widget:YouTube|id=Qmgq0BvvZ7U}}",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}